Corporate Round - CellCentric
Investment Firm
Overview
CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.
Announced Date
Jul 11, 2023
Funding Type
Corporate Round
Highlights
Location
Europe
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
CellCentric raised $25000000 on 2023-07-11 in Corporate Round
CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.
Company Funding History
18
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Jul 11, 2023 |  Corporate Round - CellCentric | 1 | - | 25.0M |
| Jul 24, 2024 | Venture Round - CellCentric | 1 | - | 35.0M |
| Jun 01, 2017 | Venture Round - CellCentric | 1 | - | undefined |
| Jun 25, 2013 | Venture Round - CellCentric | 4 | - | 6.6M |
Recent Activity
There is no recent news or activity for this profile.